Glenmark Life Sciences Limited (GLS)의 가격은 얼마입니까?

Glenmark Life Sciences Limited (GLS)의 가격은 $12.18입니다.

Glenmark Life Sciences Limited (GLS)의 시가 총액은 무엇입니까?

Glenmark Life Sciences Limited (GLS)의 시가 총액은 $1.49B입니다.

Glenmark Life Sciences Limited (GLS) 가격 이력

Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011, specializes in the creation, manufacturing, and distribution of high-value active pharmaceutical ingredients (APIs). These APIs are utilized across a wide array of chronic therapeutic areas. The company's diverse portfolio includes compounds for managing cardiovascular diseases (e.g., Olmesartan, Rosuvastatin, Amiodarone), central nervous system conditions (such as Oxcarbazepine, Topiramate, Lacosamide), and diabetes (including Glimepiride, Teneligliptin, Linagliptin). Additionally, they produce APIs for pain management (Etoricoxib, Lornoxicam), gastro-intestinal disorders, anti-infective treatments, respiratory ailments, and anti-emetic applications, featuring products like Atovaquone, Fluconazole, and Esomeprazole Magnesium. Beyond API production, Glenmark Life Sciences offers contract development and manufacturing (CDMO) solutions to numerous multinational and specialty pharmaceutical firms. Operating as a subsidiary of Glenmark Pharmaceuticals Limited, the company exports its products worldwide, reaching markets in Europe, North America, Latin America, and Japan.

연도	성과
2025	8.46%
2024	56.27%
2023	49.21%
2022	-36.04%
2021	0.00%

연도

성과

2025

8.46%

2024

56.27%

2023

49.21%

2022

-36.04%

2021

0.00%

회사	주가	변동률 1년%	국가
MERCK Kommanditgesellschaft auf Aktien MER.SW	$171.67	-	DE
Merck KGaA MRK.DE	$166.00	32.21%	DE
Takeda Pharmaceutical Company Limited 4502.T	$37.84	25.57%	JP
Galderma Group AG GALD.SW	$223.44	28.17%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$21.19	17.04%	IN

회사

주가

변동률 1년%

국가